BridgeBio Pharma Inc Capital Reinvestment Ratio

Latest as of June 2024: 0.03x

BridgeBio Pharma Inc capital reinvestment ratio. BridgeBio Pharma Inc (BBIO) has a Capital Reinvestment Ratio of 0.03x as of June 2024, meaning it reinvests 0% of its operating cash flow ($74.70 Million) in capital expenditures ($2.45 Million). Check BridgeBio Pharma Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.03x

Capex / Operating Cash Flow

Operating Cash Flow

$74.70 Million

USD

Capital Expenditures

$2.45 Million

USD

Data as of

Jun 2024

Most recent filing

BridgeBio Pharma Inc Capital Reinvestment Ratio by Year (None–None)

BridgeBio Pharma Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see BBIO cash flow metrics.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow